Sysmex demonstrates confidence and investment in OGT and the United Kingdom Oxford, UK – 26 February 2019. Oxford Gene Technology (OGT), The Molecular Genetics Comp...

Following the news (25 February 2019) that Roche has entered into a definitive merger agreement to fully acquire Spark Therapeutics for $4.3bn, Tajekesa Chapman, Phar...

Despite having demonstrated impressive efficacy in terms of response rates, CAR-T cell therapies are faced with several issues. Complex manufacturing leads to delayed...

ZURICH, Switzerland, March 04, 2019 / --NovaGo Therapeutics AG, a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral ...

A new study led by UCLA researchers has fuelled further concerns over the controversial gene-editing experiment that was performed in China last year. The study su...

Elderly to feel fitter, faster and stronger Researchers from The University of Texas Medical Branch at Galveston have developed a promising drug that has proven to s...

Researchers have been advancing methods to generate insulin-producing beta cells from pluripotent stem cells (PSC) for the clinical treatment of type 1 diabetes (T1D)...

Researchers have engineered "antibody-like" T cell receptors that can specifically stick to cells infected with cytomegalovirus, or CMV, a virus that causes lifelong ...

Inovio Pharma spinout Geneos Therapeutics has closed a $10.5 million first-round financing that will help launch its R&D in neoantigen-targeting cancer immunothe...

The second and final $12 million tranche was triggered after the company met development and regulatory objectives, ac...